Safety and Feasibility of CD19 CAR T Cells Using CliniMACS Prodigy for Relapsed/Refractory CD19 Positive ALL and NHL

Clinical trial NCT05779930 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05779930
Sponsor: Nationwide Children's Hospital
Status: NOT_YET_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia, in Relapse Non-Hodgkin's Lymphoma, Relapsed Non-Hodgkin's Lymphoma Refractory Acute Lymphoblastic Leukemia With Failed Remission B-cell Non Hodgkin Lymphoma B Cell Leukemia

Start date: 2025-10-01
Primary completion: 2030-12-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.